Natco Pharma Ltd (NSE:NATCOPHARM)
₹ 1196.15 -4.5 (-0.37%) Market Cap: 214.17 Bil Enterprise Value: 199.39 Bil PE Ratio: 15.54 PB Ratio: 3.68 GF Score: 82/100

Q2 2020 Natco Pharma Ltd Earnings Call Transcript

Nov 13, 2019 / 05:30AM GMT
Release Date Price: ₹560.15 (-3.19%)
Operator

Ladies and gentlemen, good day and welcome to the NATCO Pharma Limited Q2 FY '20 Earnings Conference Call hosted by Edelweiss Securities Ltd.

(Operator Instructions) I now hand the conference over to Mr. Deepak Malik of Edelweiss. Thank you, and over to you, sir.

Deepak Malik
Edelweiss Securities Ltd., Research Division - Analyst

Thank you. And good evening and good morning, everyone. On behalf of Edelweiss, I welcome you all for NATCO Pharma's Second Quarter FY '20 Earnings Call. Today we have with us the senior management of the company represented by Mr. Rajeev Nannapaneni, Vice Chairman and CEO; and Mr. Rajesh Chebiyam, Vice President, Acquisitions, Institutional Equity Investor Management and Corporate Communications. I would like to hand over the conference to Mr. Rajesh for the opening remarks. Over to you, Rajesh.

Rajesh Chebiyam
NATCO Pharma Limited - VP of Acquisitions, Institutional Investor Management & Corporate Communications

Sure. Deepak, thank you very much. As always. Welcome,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot